Product and development visualizations

The development direction
A strain name and a large count at manufacture are insufficient to describe the finished product through its shelf life. The project must specify strain identity, count timing, storage conditions and an appropriate method. C24 compares a postbiotic route with live cultures; a postbiotic is not a live probiotic.
Candidate concepts
The following IDs are development briefs for technical discussion. They are not stocked SKUs, validated formulas or approved consumer products.
| Concept | Direction | Review focus |
|---|---|---|
| C21 | Named strain and mild sweetener | Strain designation, counting method and label basis |
| C22 | Named strain without mint | Viability and flavor compatibility |
| C23 | Named strain and pack-barrier comparison | Release count, end-of-life count and storage |
| C24 | Postbiotic and live-culture comparison | A postbiotic is not a live probiotic and must not be labeled as live CFU |
What can be customized
- Named strain and supplier documentation
- Sweetener and flavor compatibility
- Moisture and oxygen protection
- Can closure and opening frequency
OEM, ODM, CRO and CDMO scopes can be discussed for this series. The formulation, ingredient form, loading, flavor, pouch dimensions, seal method, pack count and artwork are evaluated together. No standard dose, shelf life, MOQ or production lead time is assumed.
Validation before a specification
- Viable count method and recovery from the pouch
- Counts at release and proposed end of shelf life
- Real-time stability under intended storage
- Evidence for the specific strain and intended use
Record sample ID, formulation version, pack version, test conditions, method and acceptance criteria. A supplier COA describes the stated material and batch; it does not replace finished-product evaluation. Separate an observation from a specification and from a marketing claim.
From sample to a controlled project
Start with a target country and intended adult use. Describe the flavor profile and pack you want, then compare a limited set of numbered samples. Use the same evaluation sheet for each version. Decide which differences justify another prototype before approving artwork or ordering commercial packaging. Changes after approval require review of the formula, label, testing and quotation.
Relevant documents include ingredient specifications, a sample comparison record, the proposed finished-product specification, packaging drawings, applicable test methods, a stability plan and a claim review. Availability and authorship of each document are agreed in the project scope.
Use the sample evaluation guide or prepare a project specification.
Sources and scope
These references inform the questions used in development review. They do not certify our company or demonstrate the safety, efficacy or market authorization of a finished oral care pouch. Updated when the underlying guidance or project evidence changes.
Project questions
Is this a ready-to-sell formula?
No. These are candidate development directions. A saleable specification, label, supporting evidence and market conditions must be confirmed for the project.
Can this direction be made for my brand?
OEM, ODM, CRO and CDMO project scopes can be discussed. Send your target market, ingredient or sensory brief and preferred packaging for feasibility review.
What determines the quote?
Formula complexity, ingredient requirements, number of prototypes, testing, packaging, SKU count and order quantity determine the scope. MOQ and timing are confirmed in the quotation.
Bring your project into focus.
Tell us your target market, formulation direction and pack requirements. Scope, specifications and commercial terms are reviewed for your project.
Request a quote